Shanghai Pharmaceuticals Holding Co Ltd
Company Profile
Business description
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
Contact
No. 200 Taicang Road
Shanghai Pharmaceutical Building
Shanghai200020
CHNT: +86 2163730908
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
49,608
Stocks News & Analysis
stocks
Cheap retail REIT with an attractive yield
stocks
Expanding store network for ASX listed retailer
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,098.20 | 38.70 | 0.43% |
| CAC 40 | 8,384.01 | 33.14 | 0.40% |
| DAX 40 | 24,894.01 | 258.71 | 1.05% |
| Dow JONES (US) | 51,671.03 | 468.77 | 0.92% |
| FTSE 100 | 10,430.62 | 41.10 | -0.39% |
| HKSE | 24,533.35 | 309.32 | -1.25% |
| NASDAQ | 26,683.94 | 795.10 | 3.07% |
| Nikkei 225 | 69,750.69 | 433.19 | 0.62% |
| NZX 50 Index | 13,386.03 | 25.44 | 0.19% |
| S&P 500 | 7,554.29 | 122.83 | 1.65% |
| S&P/ASX 200 | 8,883.10 | 42.70 | 0.48% |
| SSE Composite Index | 4,098.85 | 2.38 | 0.06% |